top of page
Laboratory picture showing cell and gene manipulation, illustating WP1

Women in Science

Interviews with

Let’s meet another “Woman in Science” part of our MSCA GET-IN network!
Chiara Martinello, PhD student at the Côte d’Azur University in Nice interviewed Els Verhoeyen to get to know more about her life and how she became the resourceful and brilliant scientist she is, with some insights on what is the reality to be a “Woman in Science” nowadays.

​

Els Verhoeyen is a research director at the Institute for Health and Medical Research (INSERM) with a dual affiliation: the international center for infectiology research (CIRI) in Lyon (France) and the Mediterranean Centre for Molecular Medicine (C3M) in Nice (France). Her research is focused on the development of lentiviral vectors and gene editing tools for gene therapy, especially for blood diseases. She is also the president of the French Society of Cell and Gene Therapy (SFTCG) and a board member of the European Society of Gene and Cell Therapy (ESGCT).

els-verhoeyen

Meet Els Verhoeyen

Marianne Carlon

Marianne Carlon is a recently appointed assistant professor at the world-class university KU Leuven, where she is at the forefront of developing innovative therapeutic approaches for people living with chronic lung diseases like cystic fibrosis – thanks also to her successful involvement in a current MSCA-funded European research network. 

​

She is a supportive mentor for students at different career stages, and a nature and sports enthusiast in her free time. We have interviewed her to learn more about her life and career – and to reflect on what it means to be a woman in STEM today.

Meet Prof. Marianne Carlon

GET-IN logo and organisation name

This project has received funding from the European Union’s Framework Programme for Research and Innovation, Horizon Europe under Grant Agreement No. 101119880

ON5b, Herestraat 49, Box 1023

3000 Leuven, Belgium

Follow us on 

  • Linkedin
Partner logos

©2023 by GET-IN. Made with pride by Websters

Funded by the European Union banner
bottom of page